MultiValent Biotherapies is a biotechnology company.
MultiValent Biotherapies has raised $27.4M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
MultiValent Biotherapies's investors include Coherent Biopharma.
MultiValent Biotherapies is headquartered in Los Altos, United States.
MultiValent Biotherapies is a biotechnology company.
MultiValent Biotherapies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MultiValent Biotherapies — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/multivalent-biotherapies. Accessed November 12, 2026.
VCBacked. (2026). MultiValent Biotherapies — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/multivalent-biotherapies
{{cite web |title=MultiValent Biotherapies — Funding & Investors |url=https://www.vcbacked.co/company/multivalent-biotherapies |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MultiValent Biotherapies? Request a listing update